Court reinstates part of $348M verdict against provider in whistleblower case
A portion of a $347.9 million verdict against a nursing home provider was reinstated late last week by a federal appeals court in an ongoing False Claims Act case.
A portion of a $347.9 million verdict against a nursing home provider was reinstated late last week by a federal appeals court in an ongoing False Claims Act case.
Four skilled nursing facilities and two financial consultants they used to bill for therapy services agreed last week to a $6 million settlement to resolve fraud allegations.
A for-profit hospice company and its owner agreed to pay $1.2 million to resolve allegations that the company fraudulently billed Medicare and Medicaid for hospice services.
A former certified nursing assistant at an Illinois continuing care retirement community is suing her ex-employer for more than $75,000 and reinstatement of her job, alleging that she was fired for reporting a resident’s mistreatment claim.
Not surprisingly, different federal courts have staked out different positions on the standard for liability under a worthless services complaint.
A federal judge has dismissed a former Brookdale Senior Living employee’s False Claims Act suit against the company while leaving the door open for an amended complaint, according to published reports
A hospice company that hired medical directors with close ties to nursing homes to better pursue allegedly fraudulent practices has agreed to a $4 million settlement with the U.S. Justice Department.
Two Florida nursing homes and a hospital allowed a hospice company to provide free services in exchange for patient referrals, according to recently unsealed whistleblower charges.
A whistleblower can continue to pursue charges that a Nevada healthcare network routinely admitted people as hospital inpatients when they should have been placed in observation status, a federal appeals court recently ruled.
Long-term care pharmacy Omnicare will not face False Claims Act penalties for drug packaging practices that apparently ran afoul of safety regulations. The U.S. Supreme Court has declined to take up the case, meaning that an appeals court ruling in Omnicare’s favor will stand.